Brawn Biotech Limited (BOM:530207)

Brawn Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	61	49	60	50	52	66
Market Cap Growth	-9.31%	-18.75%	20.85%	-4.61%	-21.49%	18.50%
Enterprise Value	59	46	56	47	48	63
Last Close Price	20.27	16.25	20.00	16.55	17.35	22.10
PS Ratio	0.35	0.36	0.36	0.22	0.60	0.19
PB Ratio	1.64	1.45	1.19	0.79	0.72	0.75
P/TBV Ratio	1.64	1.45	1.19	0.79	0.72	0.75
P/FCF Ratio	-	-	-	22.33	-	198.98
P/OCF Ratio	-	102.80	-	15.62	27.72	198.98
EV/Sales Ratio	0.34	0.34	0.34	0.21	0.56	0.18
EV/FCF Ratio	-	-	-	21.32	-	188.75
Net Debt / Equity Ratio	-0.05	-0.06	-0.08	-0.07	-0.03	-0.04
Net Debt / EBITDA Ratio	0.59	0.11	0.26	1.48	0.11	0.70
Net Debt / FCF Ratio	-	1.03	10.54	-1.97	2.06	-11.89
Asset Turnover	-	0.77	1.13	1.57	0.62	2.05
Inventory Turnover	-	1.47	2.69	4.06	2.77	93.01
Quick Ratio	-	0.39	0.67	0.73	0.63	2.19
Current Ratio	-	1.88	2.02	1.67	1.93	2.60
Return on Equity (ROE)	-	-41.30%	-21.93%	-12.83%	-20.54%	-6.10%
Return on Assets (ROA)	-	-6.69%	-6.71%	-1.79%	-9.30%	-2.20%
Return on Invested Capital (ROIC)	-13.81%	-47.91%	-29.67%	-6.30%	-26.72%	-6.96%
Return on Capital Employed (ROCE)	-	-16.80%	-19.30%	-6.30%	-27.60%	-6.70%
Earnings Yield	-1.30%	-35.69%	-20.78%	-17.48%	-31.59%	-8.30%
FCF Yield	-	-3.98%	-0.63%	4.48%	-2.10%	0.50%
Total Shareholder Return	4.09%	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.